Skye Bioscience (SKYE) Other Operating Expenses (2012 - 2025)
Skye Bioscience (SKYE) posted quarterly Other Operating Expenses of $179987.0 for Q4 2025, up 28.16% year-over-year from $140434.0 in Q4 2024, and up 96.92% quarter-over-quarter from $91400.0 in Q3 2025.
Skye Bioscience (SKYE) Other Operating Expenses (2012 - 2025) Analysis & Trends
Skye Bioscience (SKYE) has reported Other Operating Expenses for 8 consecutive years, with $179987.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 28.16% year-over-year to $179987.0; the TTM figure through Mar 2026 stood at $360750.0 (up 69.15% YoY), while the FY2025 annual figure was $360750.0, down 73.44% from the prior year.
- Other Operating Expenses climbed to $179987.0 in Q4 2025 per SKYE's latest filing, from $91400.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.1 million in Q1 2024 and bottomed at -$307086.0 in Q1 2023.
- Historically, Other Operating Expenses has averaged $201725.1 across 3 years, with a median of $91400.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Operating Expenses soared 472.91% — and 2025, when it increased 25.49%.
- Skye Bioscience's Other Operating Expenses stood at -$307086.0 in 2023, then surged by 145.73% to $140434.0 in 2024, then rose by 28.16% to $179987.0 in 2025.
- Business Quant data shows SKYE's Other Operating Expenses at $179987.0 in Q4 2025, $91400.0 in Q3 2025, and $89363.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 179,987.00 |
| Sep 30, 2025 | 91,400.00 |
| Jun 30, 2025 | 89,363.00 |
| Dec 31, 2024 | 140,434.00 |
| Sep 30, 2024 | 72,837.00 |
| Mar 31, 2024 | 1.15 Mn |
| Mar 31, 2023 | -307,086.00 |
| Mar 31, 2017 | 1.10 Mn |
| Dec 31, 2016 | 213,200.00 |
| Dec 31, 2014 | 1.20 Mn |
| Apr 30, 2014 | 4,853.00 |
| Dec 31, 2013 | -237,826.00 |
| Jul 31, 2013 | -1,684.00 |
| Jan 31, 2013 | 6,506.00 |
| Oct 31, 2012 | 9,045.00 |
| Apr 30, 2012 | 550.00 |